BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23778007)

  • 21. A novel PRKAG2 mutation in a Chinese family with cardiac hypertrophy and ventricular pre-excitation.
    Yang KQ; Lu CX; Zhang Y; Yang YK; Li JC; Lan T; Meng X; Fan P; Tian T; Wang LP; Liu YX; Zhang X; Zhou XL
    Sci Rep; 2017 May; 7(1):2407. PubMed ID: 28546535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation.
    Banerjee SK; McGaffin KR; Huang XN; Ahmad F
    Biochim Biophys Acta; 2010 Feb; 1802(2):284-91. PubMed ID: 20005292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome.
    Vaughan CJ; Hom Y; Okin DA; McDermott DA; Lerman BB; Basson CT
    J Cardiovasc Electrophysiol; 2003 Mar; 14(3):263-8. PubMed ID: 12716108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
    Burwinkel B; Scott JW; Bührer C; van Landeghem FK; Cox GF; Wilson CJ; Grahame Hardie D; Kilimann MW
    Am J Hum Genet; 2005 Jun; 76(6):1034-49. PubMed ID: 15877279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversial molecular functions of CBS versus non-CBS domain variants of PRKAG2 in arrhythmia and cardiomyopathy: A case report and literature review.
    Gong X; Yu P; Wu T; He Y; Zhou K; Hua Y; Lin S; Wang T; Huang H; Li Y
    Mol Genet Genomic Med; 2022 Jul; 10(7):e1962. PubMed ID: 35588295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis.
    Oliveira SM; Ehtisham J; Redwood CS; Ostman-Smith I; Blair EM; Watkins H
    J Mol Cell Cardiol; 2003 Oct; 35(10):1251-5. PubMed ID: 14519435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.
    Arad M; Moskowitz IP; Patel VV; Ahmad F; Perez-Atayde AR; Sawyer DB; Walter M; Li GH; Burgon PG; Maguire CT; Stapleton D; Schmitt JP; Guo XX; Pizard A; Kupershmidt S; Roden DM; Berul CI; Seidman CE; Seidman JG
    Circulation; 2003 Jun; 107(22):2850-6. PubMed ID: 12782567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage disease.
    Hu D; Hu D; Liu L; Barr D; Liu Y; Balderrabano-Saucedo N; Wang B; Zhu F; Xue Y; Wu S; Song B; McManus H; Murphy K; Loes K; Adler A; Monserrat L; Antzelevitch C; Gollob MH; Elliott PM; Barajas-Martinez H
    EBioMedicine; 2020 Apr; 54():102723. PubMed ID: 32259713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using exome sequencing to identify the cause of myocardial hypertrophy in a Chinese family.
    Pu T; Guo Q; Cao R; Xu R; Sun K; Chen S
    Mol Med Rep; 2015 Sep; 12(3):3662-3666. PubMed ID: 25997934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRKAG2 mutations presenting in infancy.
    Torok RD; Austin SL; Phornphutkul C; Rotondo KM; Bali D; Tatum GH; Wechsler SB; Buckley AF; Kishnani PS
    J Inherit Metab Dis; 2017 Nov; 40(6):823-830. PubMed ID: 28801758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the pathogenic effects of missense variants causing PRKAG2 cardiomyopathy.
    Komurcu-Bayrak E; Kalkan MA; Coban N; Ozsait-Selcuk B; Bayrak F
    Arch Biochem Biophys; 2022 Sep; 727():109340. PubMed ID: 35787834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AKT-mTOR signaling-mediated rescue of
    Zhuo J; Geng H; Wu X; Fan M; Sheng H; Yao J
    Cardiovasc Diagn Ther; 2022 Jun; 12(3):360-369. PubMed ID: 35800350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac manifestations of PRKAG2 mutation.
    Banankhah P; Fishbein GA; Dota A; Ardehali R
    BMC Med Genet; 2018 Jan; 19(1):1. PubMed ID: 29298659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome.
    Patel VV; Arad M; Moskowitz IP; Maguire CT; Branco D; Seidman JG; Seidman CE; Berul CI
    J Am Coll Cardiol; 2003 Sep; 42(5):942-51. PubMed ID: 12957447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.
    Gollob MH; Green MS; Tang AS; Roberts R
    Curr Opin Cardiol; 2002 May; 17(3):229-34. PubMed ID: 12015471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.
    Gollob MH; Green MS; Tang AS; Gollob T; Karibe A; Ali Hassan AS; Ahmad F; Lozado R; Shah G; Fananapazir L; Bachinski LL; Roberts R
    N Engl J Med; 2001 Jun; 344(24):1823-31. PubMed ID: 11407343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5'-AMP-activated protein kinase, to human chromosome 7q36.
    Lang T; Yu L; Tu Q; Jiang J; Chen Z; Xin Y; Liu G; Zhao S
    Genomics; 2000 Dec; 70(2):258-63. PubMed ID: 11112354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRKAG2 gene mutation indicating myocardial hypertrophy and Wolff-Parkinson-White syndrome in a 28-year-old woman.
    Xu Y; Li J; Lan T; Lu M
    Eur Heart J Cardiovasc Imaging; 2024 May; 25(6):e171. PubMed ID: 38270345
    [No Abstract]   [Full Text] [Related]  

  • 39. High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations.
    Thevenon J; Laurent G; Ader F; Laforêt P; Klug D; Duva Pentiah A; Gouya L; Maurage CA; Kacet S; Eicher JC; Albuisson J; Desnos M; Bieth E; Duboc D; Martin L; Réant P; Picard F; Bonithon-Kopp C; Gautier E; Binquet C; Thauvin-Robinet C; Faivre L; Bouvagnet P; Charron P; Richard P
    Europace; 2017 Apr; 19(4):651-659. PubMed ID: 28431061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High risk of sudden death associated with a PRKAG2-related familial Wolff-Parkinson-White syndrome.
    Zhang LP; Hui B; Gao BR
    J Electrocardiol; 2011; 44(4):483-6. PubMed ID: 20381067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.